JBIO · Jade Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Atlas Venture Fund XII, L.P. 10% Owner | ▼ Sell | Other | 2,327,909 Shares held | 7/15/2022 | View profile |
| Fairmount Funds Management LLC Director | ▲ Buy | Grant | 1,897,677 Shares held | 10/6/2025 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▼ Sell | Other | 1,287,858 Shares held | 4/28/2025 | View profile |
| Andrew James King See Remarks | ▲ Buy | Grant | 386,113 Shares held | 2/12/2026 | View profile |
| Tom Frohlich Chief Executive Officer | ▲ Buy | Grant | 86,331 Shares held | 2/12/2026 | View profile |
| Bradford D. Dahms Chief Financial Officer | ▲ Buy | Grant | 37,813 Shares held | 2/12/2026 | View profile |
| Elizabeth Balta See Remarks | ▲ Buy | Grant | 28,125 Shares held | 2/12/2026 | View profile |
| GRAYZEL DAVID S. | ▼ Sell | Open Market | 14,502 Shares held | 4/9/2024 | View profile |
| Benjamin T. Dake See Remarks | ▲ Buy | Option Exercise | 14,252 Shares held | 8/1/2024 | View profile |
| Hunter Gillies CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 5,602 Shares held | 6/13/2024 | View profile |
| George A. Eldridge SEE REMARKS | ▼ Sell | Open Market | 5,022 Shares held | 6/14/2024 | View profile |
| NIVEN RALPH Chief Scientific Officer | ▼ Sell | Open Market | 1,609 Shares held | 2/5/2024 | View profile |
| Marinus Verwijs SENIOR VICE PRESIDENT, CMC | ▼ Sell | Open Market | 0 Shares held | 6/14/2024 | View profile |
| Timothy P. Noyes CHIEF EXECUTIVE OFFICER | ▼ Sell | Open Market | 0 Shares held | 5/16/2024 | View profile |
Transaction History
| Elizabeth Balta | ▲ Buy | Grant | 28,125 | $0 | 2/12/2026 |
| Bradford D. Dahms | ▲ Buy | Grant | 37,813 | $0 | 2/12/2026 |
| Tom Frohlich | ▲ Buy | Grant | 78,750 | $0 | 2/12/2026 |
| Andrew James King | ▲ Buy | Grant | 41,250 | $0 | 2/12/2026 |
| Fairmount Funds Management LLC | ▲ Buy | Grant | 1,333,126 | $12.2M | 10/6/2025 |
| Tom Frohlich | ▲ Buy | Open Market | 6,000 | $44K | 5/16/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 1,062,326 | — | 4/28/2025 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 1,507 | $3K | 8/1/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 11,454 | $20K | 7/31/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 928,110 | $1.5M | 6/17/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 15,000 | $32K | 6/14/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 15,000 | $375K | 6/14/2024 |
| Marinus Verwijs | ▲ Buy | Option Exercise | 10,600 | $155K | 6/14/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 10,600 | $265K | 6/14/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 6,000 | $13K | 6/13/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 6,000 | $147K | 6/13/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $9K | 5/17/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 86 | $2K | 5/17/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 3,914 | $82K | 5/17/2024 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 10,000 | $21K | 5/16/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 8,707 | $187K | 5/16/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,293 | $28K | 5/16/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 1,981 | $42K | 5/2/2024 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 10,000 | $21K | 5/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 9,035 | $184K | 5/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 965 | $20K | 5/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,357 | $27K | 5/1/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 6,853 | $15K | 4/17/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 6,447 | $144K | 4/17/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 338 | $8K | 4/17/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 68 | $2K | 4/17/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $7K | 4/17/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 3,689 | $82K | 4/17/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 311 | $7K | 4/17/2024 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 10,000 | $21K | 4/16/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 4,491 | $110K | 4/16/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 5,509 | $137K | 4/16/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 771 | $21K | 4/10/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 7,500 | $16K | 4/10/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 6,729 | $180K | 4/10/2024 |
| GRAYZEL DAVID S. | ▼ Sell | Open Market | 11,882 | $334K | 4/9/2024 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 10,000 | $21K | 4/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 4,502 | $130K | 4/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,647 | $49K | 4/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 2,851 | $88K | 4/1/2024 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,000 | $32K | 4/1/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 3,325 | $35K | 4/1/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 3,325 | $106K | 4/1/2024 |
| Marinus Verwijs | ▲ Buy | Option Exercise | 5,300 | $77K | 4/1/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 3,796 | $110K | 4/1/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 1,504 | $45K | 4/1/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 12,495 | $27K | 4/1/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 12,495 | $390K | 4/1/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 9,000 | $19K | 3/28/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 9,000 | $266K | 3/28/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 11,068 | $310K | 3/27/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 11,068 | $117K | 3/27/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 3,432 | $36K | 3/25/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 3,432 | $96K | 3/25/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 2,764 | $73K | 3/19/2024 |
| Marinus Verwijs | ▲ Buy | Option Exercise | 5,300 | $77K | 3/19/2024 |
| Marinus Verwijs | ▼ Sell | Open Market | 2,536 | $65K | 3/19/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $7K | 3/18/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 3,000 | $6K | 3/18/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 613 | $16K | 3/18/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 20,557 | $44K | 3/18/2024 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 14,500 | $154K | 3/18/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 27,476 | $707K | 3/18/2024 |
| Benjamin T. Dake | ▼ Sell | Open Market | 7,581 | $201K | 3/18/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 6,387 | $165K | 3/18/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 2,016 | $4K | 3/13/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 2,016 | $50K | 3/13/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 2,051 | $4K | 3/12/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 2,051 | $51K | 3/12/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 3,423 | $86K | 3/11/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 10 | $263 | 3/11/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 3,433 | $7K | 3/11/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 114 | $244 | 3/8/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 114 | $3K | 3/8/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 8,975 | $220K | 3/7/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 8,975 | $19K | 3/7/2024 |
| George A. Eldridge | ▲ Buy | Option Exercise | 22,386 | $48K | 3/7/2024 |
| George A. Eldridge | ▼ Sell | Open Market | 22,386 | $560K | 3/7/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 511 | $889 | 2/23/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 511 | $10K | 2/23/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 3,489 | $6K | 2/20/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 2,591 | $52K | 2/20/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 898 | $18K | 2/20/2024 |
| NIVEN RALPH | ▼ Sell | Open Market | 4,600 | $80K | 2/5/2024 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,400 | $2K | 2/5/2024 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 3,200 | $7K | 2/5/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $7K | 1/17/2024 |
| Hunter Gillies | ▼ Sell | Open Market | 4,000 | $78K | 1/17/2024 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,400 | $2K | 1/5/2024 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,474 | $48K | 1/5/2024 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 3,200 | $7K | 1/5/2024 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,126 | $40K | 1/5/2024 |
| Hunter Gillies | ▲ Buy | Option Exercise | 125 | $268 | 12/27/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 125 | $3K | 12/27/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 4,000 | $78K | 12/20/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 9,897 | $17K | 12/14/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 9,897 | $193K | 12/14/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $7K | 12/13/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 2,103 | $4K | 12/13/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 2,103 | $41K | 12/13/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,411 | $4K | 12/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,872 | $17K | 12/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 10,283 | $166K | 12/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 3,200 | $7K | 12/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 4,600 | $75K | 12/5/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,400 | $2K | 12/5/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,413 | $4K | 11/27/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 10,104 | $22K | 11/27/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 12,517 | $203K | 11/27/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 4,990 | $11K | 11/24/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 4,920 | $77K | 11/24/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 70 | $1K | 11/24/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 11/22/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 6,970 | $15K | 11/22/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 9,382 | $142K | 11/22/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 4,200 | $7K | 11/22/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 9,600 | $21K | 11/22/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 13,800 | $207K | 11/22/2023 |
| Marinus Verwijs | ▼ Sell | Open Market | 970 | $10K | 11/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,092 | $11K | 11/1/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 30 | $450 | 9/7/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 30 | $64 | 9/7/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,413 | $4K | 9/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 1,518 | $3K | 9/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 3,931 | $59K | 9/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 8/7/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 541 | $9K | 8/7/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,871 | $17K | 8/7/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 9,742 | $151K | 8/7/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 5,478 | $12K | 7/28/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 5,478 | $99K | 7/28/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 4,522 | $10K | 7/17/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 4,522 | $82K | 7/17/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 7/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,871 | $17K | 7/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 10,283 | $171K | 7/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 7/5/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 7/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,031 | $35K | 7/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 219 | $4K | 7/5/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 10,000 | $21K | 7/3/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 10,000 | $180K | 7/3/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 10,268 | $167K | 6/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 15 | $255 | 6/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,871 | $17K | 6/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 6/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 6/5/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 6/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,250 | $37K | 6/5/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 65 | $113 | 5/19/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 65 | $1K | 5/19/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 1,090 | $2K | 5/17/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 1,090 | $21K | 5/17/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,413 | $4K | 5/8/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,871 | $17K | 5/8/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 1,599 | $36K | 5/8/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 8,685 | $188K | 5/8/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 5/5/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 5/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,045 | $43K | 5/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 205 | $4K | 5/5/2023 |
| Marinus Verwijs | ▼ Sell | Open Market | 759 | $16K | 5/3/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 693 | $15K | 5/2/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 15,000 | $32K | 5/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 15,000 | $309K | 5/1/2023 |
| Hunter Gillies | ▲ Buy | Option Exercise | 4,000 | $7K | 4/21/2023 |
| Hunter Gillies | ▼ Sell | Open Market | 4,000 | $78K | 4/21/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 4/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,871 | $17K | 4/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 10,283 | $187K | 4/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 4/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 1,715 | $31K | 4/5/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 535 | $10K | 4/5/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 4/5/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 15,000 | $32K | 4/3/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 9,172 | $176K | 4/3/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 5,828 | $115K | 4/3/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,870 | $17K | 3/6/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 2,412 | $4K | 3/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 10,067 | $239K | 3/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 215 | $5K | 3/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 3/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 3/6/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 45 | $1K | 3/6/2023 |
| NIVEN RALPH | ▼ Sell | Open Market | 2,205 | $52K | 3/6/2023 |
| Timothy P. Noyes | ▲ Buy | Option Exercise | 15,000 | $32K | 3/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 5,962 | $135K | 3/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 5,316 | $131K | 3/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 1,050 | $27K | 3/1/2023 |
| Timothy P. Noyes | ▼ Sell | Open Market | 2,672 | $64K | 3/1/2023 |
| Benjamin T. Dake | ▲ Buy | Option Exercise | 7,872 | $17K | 2/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 8,858 | $217K | 2/6/2023 |
| Benjamin T. Dake | ▼ Sell | Open Market | 1,426 | $36K | 2/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 650 | $1K | 2/6/2023 |
| NIVEN RALPH | ▲ Buy | Option Exercise | 1,600 | $3K | 2/6/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Jade Biosciences Schedules Conference Participation
Jade Biosciences has announced its participation in upcoming industry conferences. Such events typically provide opportunities for company leadership to engage with institutional investors and discuss business developments. The stock currently trades within its 52-week range, with analysts maintaining price targets significantly above current levels.
Jade Biosciences Schedules Conference Participation. Jade Biosciences has announced its participation in upcoming industry conferences. Such events typically provide opportunities for company leadership to engage with institutional investors and discuss business developments. The stock currently trades within its 52-week range, with analysts maintaining price targets significantly above current levels.